SUHA Pharma Consulting DMPK

Process

Our Process

Structured support from study intake to decision

Every project follows a defined workflow so scope, confidentiality and deliverables are clear before analysis begins—and so outputs are ready for your next development milestone.

Six steps

Six-step DMPK workflow from study intake to decision: Understand, Protect, Analyze, Interpret, Review, and Deliver mapped to Study, Data, Analysis, Interpretation, Translation, and Decision.
01

Understand

We align on your study objectives, protocol, available data and the development question you need answered.

You get: A shared scope and analysis plan before work begins.

02

Protect

Confidentiality, data ownership and permitted use are agreed before any confidential data exchange.

You get: Client-controlled data handling from the start.

03

Analyze

Data are processed using appropriate analytical tools, including Phoenix WinNonlin, R and Excel.

You get: Rigorous PK/TK analysis matched to your study design.

04

Interpret

PK/TK parameters, exposure, profiles and study findings are scientifically evaluated in the context of your program.

You get: Development-focused insight—not just calculated numbers.

05

Review

Calculations, tables, figures and conclusions undergo structured quality review before delivery.

You get: Outputs checked for accuracy, consistency and clarity.

06

Deliver

You receive clear, well-structured reports and supporting outputs designed to support the next development decision.

You get: Decision-ready documentation you can share with your team.

End-to-end coverage

This workflow spans the full preclinical PK/DMPK journey—from animal studies and dosing through PK/TK analysis, translational prediction, modeling and regulatory documentation.

  • Flexible project-based or fractional consulting engagements
  • Clear communication at each stage of the workflow
  • Outputs aligned to scientific and management audiences

Ready to start? Contact us to discuss your study data and timeline.